Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Soluble CD4 and dextran sulfate mediate release of gp120 from HIV-1: implications for clinical trials.

× No keyword cloud information.

24 in total

1. Effects of soluble CD4 on simian immunodeficiency virus infection of CD4-positive and CD4-negative cells.

Authors: D Schenten; L Marcon; G B Karlsson; C Parolin; T Kodama; N Gerard; J Sodroski
Journal: J Virol Date: 1999-07 Impact factor: 5.103

2. Increased neutralization sensitivity of CD4-independent human immunodeficiency virus variants.

Authors: P Kolchinsky; E Kiprilov; J Sodroski
Journal: J Virol Date: 2001-03 Impact factor: 5.103

3. Selective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120.

Authors: M Moulard; H Lortat-Jacob; I Mondor; G Roca; R Wyatt; J Sodroski; L Zhao; W Olson; P D Kwong; Q J Sattentau
Journal: J Virol Date: 2000-02 Impact factor: 5.103

4. Loss of a single N-linked glycan allows CD4-independent human immunodeficiency virus type 1 infection by altering the position of the gp120 V1/V2 variable loops.

Authors: P Kolchinsky; E Kiprilov; P Bartley; R Rubinstein; J Sodroski
Journal: J Virol Date: 2001-04 Impact factor: 5.103

5. Analysis of the interaction of the human immunodeficiency virus type 1 gp120 envelope glycoprotein with the gp41 transmembrane glycoprotein.

Authors: R Wyatt; E Desjardin; U Olshevsky; C Nixon; J Binley; V Olshevsky; J Sodroski
Journal: J Virol Date: 1997-12 Impact factor: 5.103

6. Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding.

Authors: R Wyatt; J Moore; M Accola; E Desjardin; J Robinson; J Sodroski
Journal: J Virol Date: 1995-09 Impact factor: 5.103

7. A monoclonal antibody to the CDR-3 region of CD4 inhibits soluble CD4 binding to virions of human immunodeficiency virus type 1.

Authors: J P Moore
Journal: J Virol Date: 1993-06 Impact factor: 5.103

8. gp120-independent fusion mediated by the human immunodeficiency virus type 1 gp41 envelope glycoprotein: a reassessment.

Authors: L Marcon; J Sodroski
Journal: J Virol Date: 1994-03 Impact factor: 5.103

Review 9. Anti-AIDS drug development: challenges and strategies.

Authors: P Mohan
Journal: Pharm Res Date: 1992-06 Impact factor: 4.200

10. Functional and immunologic characterization of human immunodeficiency virus type 1 envelope glycoproteins containing deletions of the major variable regions.

Authors: R Wyatt; N Sullivan; M Thali; H Repke; D Ho; J Robinson; M Posner; J Sodroski
Journal: J Virol Date: 1993-08 Impact factor: 5.103